A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway

BACKGROUND: Bcl-2 family members play an important role in the development of malignant lymphoma and can induce drug resistance in anticancer treatment. The development of small molecules targeting Bcl-2 family proteins may be a new strategy for the treatment of malignant lymphoma. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yue-Li, Jiang, Wen-Qi, Luo, Qiu-Yun, Yang, Da-Jun, Cai, Yu-Chen, Huang, Hui-Qiang, Sun, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938641/
https://www.ncbi.nlm.nih.gov/pubmed/31892356
http://dx.doi.org/10.1186/s12885-019-6169-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938641/
https://www.ncbi.nlm.nih.gov/pubmed/31892356
http://dx.doi.org/10.1186/s12885-019-6169-0

Ejemplares similares